OBJECTIVE Quantitative analysis of the quality of nuchal translucency (NT) measurements. METHODS First-trimester combined screening for Down syndrome was performed to all pregnant women attended in our Department from October 2003 to November 2009. NT was measured according to the Fetal Medicine Foundation (FMF) criteria by 20 trained obstetricians. The performance of NT measurements was retr...

In this work we study the effects of delayed feedback on vocal fold dynamics. To perform this study, we work with a vocal fold model that is made as simple as possible while retaining the spectral content characteristic of human vocal production. Our results indicate that, even with the simplest explanation for vocal fold oscillation, delayed feedback due to reflected sound in the vocal tract c...

We report a case of a 23-year-old pregnant woman, who underwent amniocentesis after ultrasound (US) examination in the first trimester which revealed a nuchal translucency thickness of 2.9 mm. Cytogenetic analysis revealed complete tetrasomy of the short arm of chromosome 9. Further US evaluation in the second trimester revealed Dandy-Walker malformation, ventriculomegaly, bilateral clubfoot, l...

Ultrasound screening is performed during early pregnancy for assessment of fetal well being and prenatal diagnosis of fetal chromosomal anomalies including measurement of nuchal translucency (NT) thickness. The drawback of current NT measurement technique is restricted with inter and intro-observer variability and inconsistency of results. Hence, we present an automated detection and measuremen...

Increased Nuchal Translucency is an indicator of increased risk for Down syndrome, which is identified by measuring Nuchal Translucency from ultrasound fetal images during 11 to 13 weeks of gestation. Increased NT is associated with chromosomal abnormalities. In this study an efficient classification system based on Discrete Wavelet Transform (DWT) is proposed to detect the normal and abnormal ...

OBJECTIVE Assess the accuracy of the nuchal translucency (NT) measurement between 11 and 13 weeks and 6 days of gestation as a sonographic marker to screen for congenital heart defects (CHD). METHODS This is a multi-center retrospective study in which singleton gestations of euploid fetuses were analyzed. NT measurement was performed in the first trimester examination when the fetal crown-rum...

Objective We sought to assess blood fl ow in relation to jugular lymphatic distension in fetuses with increased and normal nuchal translucency (NT). Study design In all, 72 fetuses with normal NT and 71 fetuses with NT > 95th percentile were evaluated. NTsize, jugular lymphatic sacs (JLS), jugular vein and ductus venosus pulsatility index for veins (PIV), and intracardiac velocities were measur...